First Time Loading...

Denali Therapeutics Inc
NASDAQ:DNLI

Watchlist Manager
Denali Therapeutics Inc Logo
Denali Therapeutics Inc
NASDAQ:DNLI
Watchlist
Price: 19.3 USD 5.41% Market Closed
Updated: May 14, 2024

Revenue Breakdown

Breakdown by Geography
Denali Therapeutics Inc

Not Available

Breakdown by Segments
Denali Therapeutics Inc

Total Revenue: 330.5m USD
100%
Atv:abeta Program License: 288.9m USD
87.4%
Cns Program License: 25m USD
7.6%
Ptv:pgrn Collaboration Agreement: 10m USD
3%
Option Research Services: 1.6m USD
0.5%
Show More
Show Less

See Also

Discover More